Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL283884 | 0.90 | MEN1 (0.46) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL4740322 | 0.88 | MEN1 (0.37) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL3519692 | 0.86 | MEN1 (0.43) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL4424463 | 0.85 | MEN1 (0.42) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL526722 | 0.84 | MEN1 (0.39) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL3147056 | 0.84 | MEN1 (0.39) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL28559339 | 0.83 | MEN1 (0.44) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL6285895 | 0.82 | MEN1 (0.41) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL6451149 | 0.81 | MEN1 (0.40) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL12933672 | 0.81 | MEN1 (0.40) | MEN1KMT2AALDH1A1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117222636-A | Deuterated compounds as CDK4/6 inhibitors | 甘李药业股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022218247-A1 | DEUTERATED COMPOUND AS CDK4/6 INHIBITOR | 甘李药业股份有限公司 | 2022-10-20 | — | — | WO | disclosed |
| US-20170259099-A1 | SILICON-CONTAINING ORGANIC ACID DERIVATIVES AS ENVIRONMENTALLY FRIENDLY AFFF EXTINGUISHING AGENTS | UNIVERSITÄT ZU KÖLN (DE) | 2017-09-14 | — | — | US | disclosed |
| US-9701704-B2 | Catalysts for (E)-selective olefin metathesis | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-07-11 | — | — | US | disclosed |
| US-20170022231-A1 | CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-01-26 | — | — | US | disclosed |
| US-8361922-B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | MATERIA, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-05-17 | — | — | US | disclosed |
| US-6291068-B1 | CORES WITH COATING LAYER, AMMONIUM POLYPHOSPHATE AND THERMOSETTING RESIN, MELAMINE MONOMER OR SURFACE TREATED LAYER | CHISSO CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-0924166-A1 | THERMOPLASTIC-COATED AMMONIUM POLYPHOSPHATE AND PROCESS FOR THE PREPARATION THEREOF | CHISSO CORPORATION (JP) | 1999-06-23 | — | — | EP | disclosed |
| US-4245122-A | USING TRICAPRYLMETHYLAMMONIUM CHLORIDE AS A PHASE TRANSFER AGENT | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1981-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022231-A1 | CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS | COASY, FDFT1, SQLE | MEN1 592/4885KMT2A 1784/4885ALDH1A1 1299/4885 |
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | ORC3, OXER1, CBR3 | MEN1 1476/4885KMT2A 2953/4885ALDH1A1 2951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.